These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20234134)

  • 1. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
    Zhou G; Ge S; Liu D; Xu G; Zhang R; Yin Q; Zhu W; Chen J; Liu X
    Cardiology; 2010; 115(3):221-8. PubMed ID: 20234134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
    Vidal C; Gómez-Hernández A; Sánchez-Galán E; González A; Ortega L; Gómez-Gerique JA; Tuñón J; Egido J
    J Pharmacol Exp Ther; 2007 Jan; 320(1):108-16. PubMed ID: 17015640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model.
    Aydin U; Ugurlucan M; Gungor F; Ziyade S; Inan B; Banach M; Kalko Y; Yasar T
    Angiology; 2009; 60(3):370-7. PubMed ID: 18796450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
    Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
    Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
    Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
    Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.
    Li JQ; Zhao SP; Li QZ; Cai YC; Wu LR; Fang Y; Li P
    Clin Chim Acta; 2006 Aug; 370(1-2):57-62. PubMed ID: 16507303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atorvastatin on expression of ICAM-1 in atherosclerotic rabbits.
    Du B; Xu G; Cao H; Cui W; Lin S; Liu Y; Qin L
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):120-6. PubMed ID: 22609871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
    Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atorvastatin and pravastatin on serum C-reactive protein.
    Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Taylor AJ
    Am Heart J; 2003 Feb; 145(2):e8. PubMed ID: 12595863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin reduces tissue factor expression in adipose tissue of atherosclerotic rabbits.
    Li JQ; Zhao SP; Li QZ; Cai YC; Wu LR; Fang Y; Li P
    Int J Cardiol; 2007 Feb; 115(2):229-34. PubMed ID: 16820231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.
    Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD
    Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model.
    Ge S; Zhou G; Cheng S; Liu D; Xu J; Xu G; Liu X
    Atherosclerosis; 2009 Jul; 205(1):74-9. PubMed ID: 19110249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term atorvastatin treatment does not modify neointimal morphology but reduces MMP-2 expression in normocholesterolemic rabbit stented arteries.
    Collin B; Busseuil D; Korandji C; Zeller M; Cottin Y; Duvillard L; Rioufol G; Pitois-Merli I; Rochette L
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):428-36. PubMed ID: 16633086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
    Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
    Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits.
    Zhao SP; Wu ZH
    Clin Chim Acta; 2005 Oct; 360(1-2):133-40. PubMed ID: 16014304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clopidogrel on vascular proliferation and apoptosis in an atherosclerotic rabbit model.
    Ren H; Li M; Feng L; Jiang J; Zhang Y; Zhang Y; Zhu X
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):617-24. PubMed ID: 20351565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome.
    Pei H; Gu J; Thimmalapura PR; Mison A; Nadler JL
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E92-E102. PubMed ID: 16118253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulating PPAR-γ expression and NO concentration, and down-regulating PAI-1 concentration in a rabbit atherosclerotic model: the possible antiatherogenic and antithrombotic effects of atorvastatin.
    Yang P; Li Y; Li JJ; Qin L; Li XY
    Int J Cardiol; 2010 Mar; 139(3):213-7. PubMed ID: 19307033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.